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Abstract
Dendritic cells (DC) play a pivotal role in transmission and dissemination of HIV-1. Earlier studies reported that DC present at
the site of infection trap virus particles via DC-SIGN and transfer the virus to the interacting naı¨ve T cells. This prompted us
to ask the question whether DC could acquire virus from infected T cells during DC-T cell interaction. To address this, we
investigated the likely transfer of virus from HIV-1 infected T cells to DC and the underlying mechanisms involved. Results
indicate that DC acquire virus from infected T cells via antigen uptake mechanism and this results in infection of DC with
expression of proteins directed by viral DNA. Further studies with HIV-1 lacking the Env protein also resulted in infection of
DC. The use of antibodies against DC-SIGN and DC-SIGN-R ruled out a role for receptor in the infection of DC. Additional
data show that DC infection is directly correlated with the ability of DC to take up antigen from infected T cells. Overall,
these studies provide evidence to suggest that HIV-1, besides infecting immune cells, also utilizes immunological
mechanism(s) to acquire and disseminate virus.
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Introduction
HIV-1 infects macrophages, dendritic cells and T cells, which
are also the key cells involved in inducing immune activation
against invading pathogens [1,2,3]. HIV-1 transmission, infection
and dissemination are facilitated by both cell-free and cell-
associated virus in vitro and in vivo [4]. However, cell-associated
virus transmission is more efficient than cell-free virus transmission
[5,6]. Thus, HIV-1 has devised several strategies to utilize this
pathway. One of the ways HIV-1 enhances viral transmission is by
converting the immunological synapse to a virological synapse
between the interacting antigen presenting cell (APC), T cell, and
other immune cells. Dendritic cells (DC) are one of the first targets
that encounter virus at the mucosal surface during transmission in
vivo [7,8]. DC present under the mucosal membrane capture cell
free virus as well as interact with infected donor cells, through the
breached epithelial layer [1]. During this process DC capture virus
particles and trans infect T cells efficiently as ‘‘Trojan Horses’’ [9].
In addition to the ability of DC to acquire virus in trans, a small
percentage of DC are also infected in cis and support virus
replication both in vivo and in vitro [10,11,12,13,14,15]. Thus, DC
play a key role in infection, virus dissemination and pathogenesis.
DC interact with pathogen infected/exposed cells in various tissue
compartments as part of the immune surveillance function in vivo
[16,17]. DC uptake antigens (from both cell membrane and
cytoplasm) from infected cells, process and present them to naı¨ve
and memory T cells. These studies indicate that there is sufficient
interaction between DC and T cells during pathogen encounter. In
HIV-1 infected individuals, activated CD4+ T lymphocytes are the
major target cells for virus replication and infected T cells are present
both in the periphery and in lymphoid organs [18,19]. Previous
studies report that when an infected DC interacts with an uninfected
T cell, captured virus in DC is transmitted to the T cells, that results in
productive infection of T cells [10,20,21,22]. However, it is not
known whether DC could acquire virus from an infected T cell
resulting in infection of DC. To address this, we cocultured infected T
cells with naı¨ve DC and evaluated the infection of DC by HIV-1. For
this purpose, we used a HIV-1 reporter proviral plasmid that codes
for EGFP before the nef open reading frame as described [23]. The
reporter virus derived from the plasmid has allowed us to measure the
expression and subcellular distribution of EGFP (driven by HIV-1
LTR) only in infected DC.
Results presented here indicate that the cell-associated virus was
taken by DC and infected DC as early as 12 hours and was
maintained for more than six days, whereas cell free virus required
2–3 days to establish productive infection in DC. Infection of DC
via infected T cell is dependent on T cell-DC contact and is
independent of viral envelope and DC-SIGN. Furthermore, the
percentage of DC infection is directly correlated with the ability of
DC to acquire cell-associated antigen, suggesting DC could
acquire virus from the infected T cells through the antigen uptake
process. Collectively, these studies for the first time indicate that
HIV-1 taken up by the DC through the antigen uptake
mechanisms establishes cis infection in DC.
PLoS ONE | www.plosone.org 1 October 2009 | Volume 4 | Issue 10 | e7470
Results
Infection of DC mediated by cell associated virus
DC generated as described in methods were cocultured with
infected lymphocytes at a ratio of 2:9:1 (DC: uninfected PBL: infected
PBL). Post coculture cells were stained for DC-SIGN, and EGFP+/
DC-SIGN+ cells were determined by flow cytometry. DC were gated
based on side scatter and forward scatter followed by doublet
discrimination gating (Fig. 1A). Single cells that are double positive
for DC-SIGN+ and EGFP+ were considered as productively infected
DC (Fig. 1A). Results from coculture experiment indicate that 7.6% of
DC were infected at 12 hours post coculture with infected
lymphocytes, whereas cell free virus did not infect DC (0%) at this
time point (Fig. 1A). Addition of cycloheximide (CHX) (10 mg/ml)
during coculture completely blocked infection of DC further
confirming that EGFP expression in infected DC was due to de novo
synthesis, and not due to cell conjugates or cell fusion. Comparison of
Mean Fluorescence Intensity (MFI) of EGFP in infected DC and
infected lymphocytes present in the same coculture (Fig. 1B), indicates
that transcription of HIV-1 LTR driven EGFP in infected DC is
significantly less compared to infected lymphocytes. DC infection was
further confirmed by fluorescence microscopy where, DC-SIGN
positive cells were EGFP also positive (Fig. 1C) as identified by the
uniform subcellular distribution of EGFP that is indicative of de novo
Figure 1. Reporter virus positive DC are the result of cis infection of DC. (A) DC were cocultured with HIV-1wt-EGFP reporter virus-infected
PBL cells in the presence or absence of cycloheximide (10 mg/ml); or infected with cell-free virus. Post coculture (12 hrs), cells were stained for DC-
SIGN. DC were gated based on side scatter and forward scatter followed by doublet discrimination (as shown in gating) and assessed for EGFP by
flow cytometry. DC-SIGN and EGFP positive cells (%) are shown in the upper right quadrant. (B) Comparison of EGFP fluorescence (MFI) in infected
lymphocytes and infected DC. Overlay of histogram of EGFP fluorescence in infected lymphocytes (green) and infected DC (red). (C) Detection of DC
expressing EGFP by immunofluorescence microscopy. Red indicates DC-SIGN positive cells; green represents EGFP positive cells; Blue represents
nuclear staining by DAPI. DC*, represents DC-SIGN and EGFP positive DC. (D) Detection of integrated HIV-1 proviral DNA in EGFP+ DC. DC were
stained for DC-SIGN, and DC-SIGN+/EGFP+ DC were sorted by FACS. Integrated proviral DNA was assessed by real time Alu-LTR Taqman assay as
described in Methods. To rule out contaminating lymphocytes in DC-SIGN+/EGFP+ sorted DC, mRNA from the sorted cells were evaluated for
presence of CD28 mRNA by real-time PCR. RPLPO was used as control. Uninfected DC, Infected PBL controls were included. (E) DC were cocultured
with HIV-1wt-EGFP reporter virus-infected PBL cells or with HIV-1wt-EGFP reporter virus-infected purified CD4+ T cells, or uninfected control cells.
Twelve hours post coculture, cells were stained for DC-SIGN and assessed for EGFP positivity by flow cytometry. Cells (%) that are positive for DC-SIGN
and EGFP are shown in the upper right quadrant. (F) DC were cocultured with either HIV-1wt-EGFP reporter virus-infected Jurkat T cells or with Jurkat
cells expressing EGFP protein. Post coculture, the cells were stained for DC-SIGN and analyzed by flow cytometry or by (G) Immunofluorescence
microscopy. DC-SIGN+/EGFP+ cells were gated based on the amount of EGFP in DC-SIGN+ cells to differentiate antigen uptake and productively
infected DC. Results from multiple donors are shown in Fig. 1H, where 200 DC were counted scanning multiple fields (Fig. S2) for each culture. Figure
represents one of 5–7 independent experiments with similar results.
doi:10.1371/journal.pone.0007470.g001
Infection of DC
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synthesized EGFP. To further validate infection in DC, integrated
proviral DNA was measured in EGFP+ DC. To assess integrated
proviral DNA, DC-SIGN+/EGFP+ DC were sorted and assessed for
integrated proviral DNA by real time Alu-LTR Taqman assay, and for
CD28 mRNA by real-time PCR. Uninfected DC and infected
lymphocytes were used as negative and positive controls, respectively.
Results indicate that integrated DNA was detected by Alu-LTR
Taqman assay in DC-SIGN+/EGFP+ DC (Fig. 1D). Additionally
these cells were also negative for CD28 mRNA (Fig. 1D), further
confirming that integrated proviral DNA detection in sorted DC was
not due to contamination of infected T cells in the culture. Together
these results indicate that EGFP expression in DC is due to integrated
proviral DNA that is indicative of cis infection. Similarly purified CD4+
T lymphocytes infected with the HIV-1wt-EGFP reporter virus also
infected DC in cell-associated manner (Fig. 1E).
DC are known to take up antigens/apoptotic cells by endocytosis,
micropinocytosis and other mechanisms [24,25]. Therefore, we next
delineated the uptake of cellular materials, including EGFP protein
from the infected T cell versus de novo synthesis of EGFP in DC. DC
were cocultured with either HIV-1wt-EGFP reporter virus-infected
Jurkat T cells or with Jurkat cells expressing EGFP protein by transient
transfection and assessed by flow cytometry. Results presented in
Fig. 1F indicate that 3.41% DC are positive for EGFP following
12 hours of cocultured with HIV-1 infected cells. We also confirmed
EGFP synthesis versus EGFP uptake in DC by fluorescence
microscopy (Fig. 1G and Fig. S2) and observed a uniform cytoplasmic
and nuclear distribution of EGFP in infected DC (upper panel),
whereas, punctuate pattern was noted in DC following EGFP uptake
(bottom panel). Similar results were observed in multiple donors
(Fig. 1H). The difference seen in the amount of EGFP in DC taking up
the antigen and infected DC was not due to differences in the amount
of EGFP in the cocultured Jurkat-EGFP cells or infected Jurkat cells
(Fig. S1D). Together these results indicate that, EGFP+ DC seen in
coculture experiment are due not to EGFP (antigen) uptake but rather
it is due to de novo synthesis of EGFP in infected DC.
Productive infection of immature and mature DC is cell
contact dependent
Next, to assess whether both immature and mature DC could
be infected with cell-associated virus, immature and mature DC
were cocultured with infected lymphocytes as described in Fig. 1.
Additionally, to differentiate the role of cell free and cell-associated
virus in DC infection, infected T cells were separated from DC via
a transwell with a pore size of 0.4 mm which will allow free virus
released from infected lymphocytes in the upper chamber to pass
to DC in the lower chamber, but prevent contact between infected
T cells and DC. Results indicate that no EGFP+ DC (0%) when
they were separated by transwell, whereas, 5.2% EGFP+DC-
SIGN+ DC was observed in mixed culture (Fig. 2A). Similar
results were observed in multiple donors (Fig. 2B), suggesting that
cell-to-cell contact is necessary for DC infection within 12 hours.
Additionally, DC from the same donors infected with cell-free
virus did not show productively infected DC at the same time
point (data not shown). Time course analysis indicates that DC-
SIGN+/EGFP+ cells remained positive for EGFP up to 6 days
post coculture (Fig. 2C). Additionally, cell-free virus released from
the infected T cells reaching the lower chamber established
infection (,0.2%) only in immature DC 3 days post exposure (6–8
infected cells per 20 high power fields were detected by
microscopy). Similar low level cell-free virus mediated DC
infection was reported previously [20,26]. These results clearly
indicate that the accelerated infection of both mature and
immature DC mediated by infected T cell is contact dependent
and is not the consequence of cell free virus infection. Since the
pore size of transwell is 0.4 mm, it further rules out the
involvement of exosomes derived from infected T cells in infecting
DC. It is important to note that, though we observed infected DC
in multiple donors, there was a wide range in percentage of
infected DC (2–8%), suggesting that the variation is due to
difference in the susceptibility and/or permissibility of DC from
different donors to support HIV-1 infection.
Figure 2. Infection of immature and mature DC by infected lymphocytes is cell-to-cell contact dependent. (A) Immature and mature
MDDC were cocultured with HIV-1wt-EGFP virus infected PBL at a ratio of 2:9:1 (DC:uninfected PBL:infected PBL) either directly or separated by a
transwell. Post coculture (12 hours) cells were stained for DC-SIGN, and analyzed by flow cytometry. Gating was extended to include lymphocytes
and doublet differentiation was applied. (B) Cell contact dependent productive infection of immature and mature DC by lymphocyte associated HIV-
1 virus in multiple donors (n = 8). (C) Time kinetics of productive infection in DC mediated by T cell associated virus. The figure is representative of
data acquired from multiple donors (n = 5). Error bars indicate S.D. of the results obtained from triplicate wells from a single donor.
doi:10.1371/journal.pone.0007470.g002
Infection of DC
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Infection of DC mediated by cell-associated virus does
not involve DC-SIGN, Mannose Receptor, CD4 or HIV-1
envelope
DC-SIGN and related C-type lectin receptors are suggested to
play a role in cis and trans infection of DC, as blocking these
receptors inhibits infection [20,27,28]. Therefore, we evaluated the
ability of anti-DC-SIGN, anti-DC-SIGN-R antibodies, Mannan,
anti-CD4 antibody, T-20 Fusion inhibitor, HIV-1 co-receptor
antagonists TAK 779 and AMD 3100 to block DC infection
mediated by cell-associated virus. AZT and Intergase inhibitor (118-
D-24) were used as control to inhibit virus replication. Additionally
cycloheximide (10 mg/ml) was used as a control for de novo synthesis
of EGFP in infected DC. As shown in Fig. 3A, HIV-1 receptor and
the co-receptor blockers failed to prevent infection of DC mediated
by infected T cells, whereas AZT and Integrase inhibitors blocked
infection by 67% and 83% at higher concentrations of 100 mM and
40 mm respectively, compared to untreated control. However they
do not block the infection as seen in cell-free virus infection. Similar
results were observed in multiple donors (n = 5). Together, these
results suggest that DC-SIGN, DC-SIGN-NR, Mannan receptors,
CD4 or the HIV-1 co-receptors are not involved in T cell mediated
infection of DC.
To assess whether presence of HIV-1 envelope is required for
virus transmission from infected T cell to DC, we used HIV-
1DEnv-EGFP virus infected T cells (pseudotyped with VSV-G
envelope expression plasmid to infect T cells). Three days post
infection, cells were washed thoroughly and cocultured with DC as
described above and assessed for DC-SIGN+/EGFP+ cells
(Fig. 3B). Results indicate that DC were infected with HIV-
1DEnv-EGFP virus as determined by flow cytometry in multiple
donors (n = 4). Flow cytometry results were validated by
fluorescence microscopy (Fig. 3C) and by real time Alu-LTR
Taqman assay (Fig. 3D). Experiments to determine the presence of
contaminating lymphocytes by evaluating the presence of CD28
mRNA in the sorted, infected DC indicate no detectable CD28
mRNA, further ruled out lymphocytes contamination. Collective-
ly, these results support that cell-associated infection of DC is
independent of both DC cell surface receptors and viral envelope.
Infection of DC is directly correlated with the ability of
DC to acquire cell-associated antigen from the
interacting cell
Results presented above indicate that transfer of virus from T cells to
DC is independent of viral envelope as well as cell surface receptors in
DC, suggesting that receptor independent mechanisms may be
involved in virus transfer. DC are known to acquire surface molecules
and cell-associated antigens from interacting cells [29,30]. To
understand whether antigen uptake mechanism is involved in virus
Figure 3. Infection of DC mediated by T cell associated virus is independent of viral envelope. (A) DC were cocultured with HIV-1wt-EGFP
reporter virus-infected PBL cells in the presence of mentioned inhibitors. Post coculture (12 hours), cells were stained for DC-SIGN. Single DC were
gated and assessed for EGFP by flow cytometry. For comparison across donors, the percentage of DC infection in absence of inhibitor was considered
as 100%. Error bars indicate S.D of results obtained from results from multiple donors (n = 3). *, denotes p,0.5. (B) CD4+ T cells were infected with
HIV-1wt-EGFP reporter virus or with HIV-1DE-EGFP reporter virus complemented with VSV-G Env expression plasmid. Three days post infection cells
were washed thoroughly and cocultured with immature MDDC in the presence or absence of cycloheximide (10 mg/ml). Post coculture (12 hours),
cells were stained for DC-SIGN and analyzed by flow cytometry, and (C) Immunofluorescence microscopy. Data are representative of five
independent experiments. (D) Detection of integrated HIV-1 proviral DNA in EGFP+ DC by Real Time Alu-LTR Taqman assay, following twelve hours
of coculture with CD4+ T cells infected with HIV-1DE-EGFP reporter virus complemented with VSV-G envelope. DC were stained for DC-SIGN, and DC-
SIGN+/EGFP+ DC were sorted by FACS sorter. Integrated proviral DNA was assessed by real time Alu-LTR Taqman assay as described in Methods. To
rule out contaminating lymphocytes in DC-SIGN+/EGFP+ sorted DC, mRNA from the sorted cells were evaluated for presence of CD28 mRNA by real-
time PCR. RPLPO was used as control.
doi:10.1371/journal.pone.0007470.g003
Infection of DC
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transfer from infected T cell to DC, we examined the interrelationship
between antigen uptake and DC infection. Immature and mature DC
were cocultured with uninfected PKH26-labeled or infected PBL,
Jurkat cells, HeLa-T4 or HEK 293T at a ratio of 1:1. DC were
assessed for PKH26 uptake, and infection (EGFP+) by flow cytometry.
As shown in Figure 4A, 93.8% of immature DC acquired PKH26
labeled material from PBL, 96.2% from Jurkat, 34.7% from Hela-T4
and 32.6% from HEK 293T cells. Whereas, mature DC cocultured
with PKH26 stained cells efficiently acquired PKH26 labeled material
from PBL (70.8%) and Jurkat cells (87.3%) but failed to acquire
PKH26 labeled material efficiently from HeLa-T4 cells (6.3%) or
HEK293T cells (15.4%). Results indicate that immature DC acquired
membrane from tested cell types to different proportions. Although the
percentage of immature and mature DC positive for PKH26 is similar
in case of PBL and Jurkat, it is important to note that the amount of
PKH26 acquired by mature DC was lower than immature DC as seen
by the MFI (Fig. 4B). These results indicate that both immature and
mature DC uptake antigen from T cell lineage more efficiently and
equally, whereas they exhibit differential ability to uptake antigen from
epithelial cells.
In addition to cytoplasmic and membrane bound antigen
uptake, APC are known to acquire membrane from the interacting
cell surface on to their own surface in the right orientation, a
phenomenon described as trogocytosis [31,32,33]. To understand
whether DC infection is mediated through this mechanism, we
evaluated the ability of DC to acquire T cell surface molecules,
CD3 and CD28, by flow cytometry. We performed surface
staining of these molecules using CD3 or CD28 specific antibodies,
which will specifically detect these molecules, if they orient on the
outer side of the membrane via trogocytosis. Results indicate that
both immature and mature DC acquired CD28 from the
interacting PBL or Jurkat (Fig. 4C). This observation was further
confirmed by confocal microscopy by staining DC with anti-CD28
antibody. Results indicate that the presence of CD28 on DC cell
surface, where speckles of CD28 was identified (Fig. 4D). Together
these results indicate that DC acquire membrane from their
interacting T cells via antigen uptake and trogocytosis.
When we compared the infection of DC within these cultures,
we also observed that there is a direct correlation between
membrane uptake and infection. In multiple donors (n = 4), at
12 hours following coculture at a ratio of 1:1 (DC: PBL) (10% of
PBL are infected) it was observed that both immature and mature
DC were infected at the highest in case of PBL (2.761.1) and
Jurkat (2.661.8) coculture, whereas, it was almost half when
Figure 4. Infected T cell mediated DC infection is directly correlated with the ability of DC to acquire antigen from T cell. (A)
Immature and mature MDDC were cocultured with PKH26-labeled PBL, Jurkat cells, HeLa-T4 or HEK 293T at a ratio of 1:1. Post coculture (12 hours)
cells were stained for DC-SIGN and the amount of PKH26 uptake by DC-SIGN positive cells were assessed by flow cytometry. DC were gated based on
side scatter and forward scatter followed by doublet discrimination. Values in upper right quadrant indicate the percentage of DC-SIGN and PKH26
positive cells. (B) Histogram overlay represent PKH26 fluorescence in immature (Red) and mature (Blue) DC, post cocultured (12 hours) with PKH-26
labeled PBL, Jurkat cells, HeLa-T4 or HEK 293T cells. The figure is representative of data obtained from experiments in four separate donors. (C)
Immature and mature DC cocultured (for 12 hours) with PBL or Jurkat T cells were stained for DC-SIGN and CD28 and evaluated by flow cytometry.
(D) Comparison of MFI of CD28 molecule on the surface of Jurkat, immature DC or mature DC cocultured with Jurkat T cells. (E) Immature DC were
cocultured with Jurkat T cells for twelve hours, cells were stained for DC-SIGN and CD28 and evaluated by Immunofluorescence microscopy, green
represents DC-SIGN, CD28 is depicted in red and DAPI staining of nucleus is shown in blue. DC alone control was included. (F) Scatter plot denotes
the correlation of PKH26 uptake and DC infection post coculture with different cell types. Each color in the plot denotes individual donor (n = 4).
Linear regression was calculated for each donor, along with the R2 value.
doi:10.1371/journal.pone.0007470.g004
Infection of DC
PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7470
immature DC were cocultured with HEK293T (1.360.54) and
HeLa-T4 (1.160.35) cells. Interestingly, mature DC did not show
any infection when cocultured with HEK293T (0.1660.07) or
HeLa-T4 (0.0860.04) cells and is directly correlated with the low/
no antigen uptake. Statistical evaluation between PKH26 uptake
by immature and mature DC from different cell type (PBL, Jurkat,
Hela-T4, HEK 293T) and associated DC infection in multiple
donors (n = 4), indicates a direct correlation between antigen
uptake and infection of DC, R2 value ranges from 0.98 to 0.73
(Fig. 4F). Together these results support that there is a strong
correlation between antigen uptake and infection of DC via T cell-
associated virus.
Blocking the ability of DC to acquire cell-associated
antigen prevents DC infection
As the ability of DC to acquire cell associated antigen and
infection of DC is directly correlated, we further investigated
whether blocking the membrane uptake will result in loss of DC
infection. DC were cocultured with infected PBL in the presence
and absence of cytochalasin D, Colchicine, AZT and evaluated for
membrane uptake as well as DC infection (Fig. 5A). Results
indicate that cytochalasin D blocked both membrane uptake and
infection (.80%) significantly, whereas Colchicine did not show
any effect of the membrane uptake or infection compared to the
no treatment group. In case of AZT, it did not affect membrane
uptake, whereas, it inhibited infection in DC by 75–80% at
100 mM compared to untreated group.
Furthermore, results using various concentrations of cyctocha-
lasin D indicate that cytochalasin D inhibited membrane uptake as
well as DC infection in a dose dependent manner (Fig. 5B). At a
concentration of 0.1 mg/ml, the antigen uptake was reduced by
67.664.7% and the infection was inhibited by 71.165.1%, where
as, at 1 mg/ml, the antigen uptake was reduced by 81.365.7% and
the infection was inhibited by 87.363.8%. Cytochalasin D at
concentrations of 5 and 10 mg/ml inhibited the antigen uptake to
more than 90% and at these concentrations there was complete
inhibition of infection in DC (Fig. 5B). Inhibition of infection was
independent of cytotoxicity induced by cyctochalasin D as
confirmed by annexin V staining in DC (data not shown).
Together these results indicate that DC might acquire virus from
infected T cells through the antigen/cell membrane uptake
mechanisms. However, there may be other molecules/pathways
such as immunological and virological synapses may be affected by
cytochalasin D.
Discussion
Both cell-free and cell-associated virus facilitates transmission,
spread and dissemination of HIV-1. However, cell-associated virus
infection has added advantages and is more effective than cell-free
virus infection. Viral dissemination through cell-to cell contact is
mediated through virological synapses, and this event is predom-
inant at the secondary lymphoid organs [34,35]. Several host
cellular proteins, such as ICAM, LFA, ZAP-70 are known to
regulate this event [36,37,38,39,40]. One of the ways these cellular
proteins regulate virus transmission is through enhancing cell-to
cell contact, ability these proteins to incorporate in the virus
particles, suggesting that viruses utilize several modes for efficient
transmission. Published studies also indicate that antiviral drugs,
AZT or neutralizing antibodies do not block the cell-associated
HIV transfer and infection completely, opposed to cell-free virus
infection [41,42]. Similarly, we observed reduction in inhibition at
higher concentrations, whereas lower concentrations (that are
required to block cell-free virus) did not show significant
inhibition. Together these findings suggest that virus transmission
also occurs through other mechanism(s) that are not well
established.
In this study, we have shown for the first time that DC acquire
virus from infected T cells utilizing the antigen uptake mechanisms
that results in DC infection. Previous studies have focused on DC
handing off virus to the interacting naı¨ve T cells as part of the
‘‘Trojan horse’’ model that results in productive infection [20,21].
However, it is not well understood whether a reverse phenomenon
is possible. This is important as DC interact with infected T cells to
sample foreign antigens for priming naı¨ve T cells. Our results
indicate that DC acquire virus from the infected cells during the
antigen uptake process that results in DC infection. Although
immature DC efficiently uptake antigen (.90% of total DC
cocultured) from T cells, infection of DC is 5–8% of the total DC
cocultured, suggesting that a small amount of virus is able to
escape the antigen processing pathway and establish infection. The
other possibility is that most of the budding virus particles that are
transferred from infected T cell to DC may not be mature as part
of the virion maturation occurs post release. A recent study by
Turville et al [43], further support our finding that DC can take up
virus from another infected DC. Envelope independent HIV-1
infection has been reported previously, in case of cells that lack
CD4 receptors [44,45]. Also the envelope deficient virus was able
to transfer from infected DC to neighboring uninfected DC [43].
This phenomenon might have a significant impact in vivo, as DC
and T cells interact at multiple sites including the site of entry
(mucosal tissue) and lymphoid structures within the infected host.
Upon infection by pathogens, various immune cells (infected and
bystander) come in contact at the lymphoid tissues for antigen
Figure 5. Blocking the ability of DC to acquire cell associated
antigens prevents DC infection. (A) DC were cocultured with
infected T cells in the presence of various inhibitors (Cytochalasin D
1 mg/ml; Colchicine 100 mg/ml; AZT 100 mM), post coculture (12 hours)
were stained for DC-SIGN and the amount of antigen uptake by DC and
percentage of productive infection of DC were evaluated by flow
cytometry. The figure is representative of data obtained from one of the
five independent donors. Error bars indicate S.D. of the results obtained
from triplicate wells from a single donor. (B) Ability of Cytochalasin D to
inhibit antigen uptake and productive infection of DC in dose
dependent manner. The figure is representative of data obtained from
one of four independent experiments. * denotes p,0.5.
doi:10.1371/journal.pone.0007470.g005
Infection of DC
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uptake, presentation, priming and induction of immune responses.
Many of these processes occur through the formation of
immunological synapses [46,47,48]. Pathogens, including HIV-1
are known to dysregulate immunological synapse and enhances
virological synapse by differentially regulating viral and host
cellular factors [7,34,49]. Utilizing this immunological process,
DC capture free virus and efficiently trans infect T cells in vivo and in
vitro. In vivo studies (animal model) indicate the presence of
productively infected T cells 3 days post-intravaginal inoculation
[50,51]. Here we address the consequence of the interaction
between an infected T cell and uninfected DC and its potential
role in viral dissemination.
Results presented here indicate that DC acquire virus from
infected T cells independent of cellular and viral receptors that are
involved in typical cell-free infections but dependent of cell-to-cell
contact, suggesting that cell-to-cell communication and/or cellular
networks are involved in virus transfer. Although results presented
above indicate that DC might acquire virus from infected cells, via
their antigen uptake mechanisms, it is not clear what kind of
material transfer occurs between T cell and DC. Based on the cell
surface ligands, their receptors involved in DC-T cell interaction,
it is possible to predict that the presence of these costimulatory
molecules might increase the affinity of cell-to cell contact though
their ligands present in DC. Based on the available information,
we proposed several scenarios that could be the source for DC
infection as shown in Fig. 6. These include: (a) uptake of budding
virus particle from the infected T cell via cell membrane uptake;
(b) uptake of various forms of infectious unintegrated viral DNA
from infected T cell cytoplasm via cytoplasmic antigen uptake; (c)
membrane transfer of assembling and budding virus from the
infected T cell and reorient on DC membrane; and (d) uptake of
cellular and nuclear content including viral antigens and viral
nucleic acids from the apoptotic infected T cells. Alternatively,
virus could also transfer from cell to cell via a cellular network
including nanotubules, and other related extensions, as DC
acquire dyes, bacteria and other pathogens from cells through
nanotubules [24,52]. Transfer of viral nuclear material, either
unintegrated viral DNA as LTR circles or linear proviral DNA
may have an effect in viral pathogenesis. It should be noted that
these unintegrated forms have varied half life, the linear
unintegrated proviral does not survive for long, but conflicting
reports suggest that the LTR ring forms may persist in the cells
and may have a role in virus persistence, even in patients on
HAART for a long duration. Alternatively DC can acquire
immature virus particle, which may not be infectious. In vivo, DC
scavenges the tissues for foreign antigens as part of normal
immune surveillance. If HIV-1 utilizes these normal DC cell
functions for virus transmission, this will have significant impact on
pathogenesis and disease progression. Clearance of virus from the
infected host will be much more difficult. Understanding the
mechanism(s) involved in contact dependent virus transfer will
further enhance our knowledge towards developing additional
antiviral strategies to prevent HIV-1 transmission.
Materials and Methods
Cell Culture
Peripheral blood mononuclear cells (PBMC) were isolated from
heparinized blood obtained from normal donors (through Central
Blood Bank, Pittsburgh following approved protocols) using Ficoll-
Hypaque gradient centrifugation. CD14+ monocytes were puri-
fied by positive selection using anti-CD14 monoclonal antibody-
coated magnetic microbeads (Miltenyi Biotech, Auburn, CA) as
described previously [53]. The purity of CD14+ cells was tested by
flow cytometry following staining with CD14 antibody, and the
results indicate .98% of isolated cells were CD14 positive (data
not shown). To obtain monocyte-derived DC (MDDC), CD14+
cells (0.56106 cells/ml) were cultured in 60-mm culture plates in a
total volume of 10 ml of medium containing 25 ng/ml IL-4 (R&D
Systems, Minneapolis, MN) and 50 ng/ml granulocyte-macro-
phage colony-stimulating factor (GM-CSF) (R&D Systems). Half
the volume of medium was replaced every other day throughout
Figure 6. Proposed model depicting the various mechanisms(s) involved in virus transfer from infected T cell to DC. This includes the
following potential mechanisms: Uptake of budding virus particle from the infected T cell via cell membrane uptake; Uptake of various forms of
infectious unintegrated viral DNA from infected T cell cytoplasm via cytoplasmic antigen uptake; Membrane transfer of assembling and budding virus
from the infected T cell and reorient on DC membrane; and Uptake of cellular and nuclear content including viral antigens and viral nucleic acids from
the apoptotic infected T cells. DC is depicted in the middle; Cell with green cytoplasm denotes infected (EGFP+) T cells with various forms of
unintegrated proviral DNA (shown in Red). Potential cell surface interacting receptors and ligands are marked in the T cells on the left.
doi:10.1371/journal.pone.0007470.g006
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the entire culture period. MDDC (7 day old) were stimulated with
LPS (Sigma-Aldrich) 1 mg/ml, and maturation of MDDC was
confirmed by phenotypic and functional analysis (Fig. S1A, B).
The flow through during the CD14+ selection of PBMC (same
donor) was collected, and the purity of the lymphocytes (PBL) was
tested by flow cytometry using CD14 and CD3 antibody. More
than 95% of isolated cells were CD142 (data not shown). PBL
(16107/ml) were stimulated with anti-CD3 (OKT3) antibody
(10 mg/ml)-coated flasks along with soluble anti-CD28 antibody
(BD Pharmingen clone 28.2) (1 mg/ml) for 3 days as described [54]
and cultured in media containing rIL-2 (5 U/ml). CD4+
lymphocytes were isolated by negative selection from PBMC,
more than 95% of isolated cells were CD4+ as tested by flow
cytometry. Stimulation and infection of CD4+ T cells was
performed in a similar way as PBL. Jurkat T cell line JJK,
HeLa-T4 and HEK 293T cells were maintained in appropriate
growth media.
Plasmids, virus preparation and infection
The construction and characterization of HIV-1 wt-EGFP proviral
plasmid has been previously described [23]. Briefly, Enhanced Green
Fluorescence Protein (EGFP) gene was inserted in the nef open reading
frame of pNL4.3 proviral plasmid and the expression of nef was driven
by ECMV Internal Ribosomal Entry Site (IRES). For studies
involving envelope deficient HIV-1DE-EGFP virus, NdeI site in the
envelope of HIV-1wt-EGFP proviral plasmid was mutated by filling
and re-ligating the blunt ends. This introduced multiple stop codons
in the reading frame of env after the end of vpu reading frame, and
deleted the expression of env. HEK293T cells (26106 per plate) were
transfected with 10 mg of HIV-1wt-EGFP construct by calcium
phosphate precipitation method [53]. Forty-eight hours post
transfection supernatants were collected, filtered through a 0.45-mm
filter to remove cellular debris, and centrifuged at 22,000 rpm for
1 h. Virus pellets were resuspended in PBS and stored in aliquots at
280uC for subsequent assays. Virus titers were measured by p24
enzyme-linked immunosorbent assay (ELISA), and multiplicity of
infection (MOI) was calculated by infecting Jurkat cells for 24 hours
and assessed by flow cytometry or by standard TZM-bl assay. PBL
and Jurkat were infected with the HIV-1wt-EGFP reporter virus at a
MOI of 0.5. Twelve hours post infection, virus was removed by
washing, and cells were maintained in appropriate media. For
infection of HEK293T and HeLa-T4 cells, the HIV-1wt-EGFP
reporter virus was pseudotyped with VSV-G envelope and the cells
were infected at a MOI of 1.0. Six hours post infection, the virus was
removed by washing and the cells were maintained in growth media.
VSV-G pseudotyped HIV-1DE-EGFP virus was produced by co-
transfecting HEK293T cells with VSV-G and HIV-1DE-EGFP
constructs by calcium phosphate precipitation method [53]. Forty-
eight hours post transfection supernatants were collected, processed
and the virus was quantitated as described above. PBL and Jurkat
were infected with the HIV-1wt-EGFP reporter virus at a MOI of
0.5. Twelve hours post infection, virus was removed by washing, and
cells were maintained in appropriate media. Transfection of HIV-
1DE-EGFP construct in the absence of VSV-G produced non-
infectious virus like particles. Similarly the virus particles released
from the T cells in the supernatant were not infectious as evaluated by
standard TZM-bl assay.
Transfection of Jurkat
Jurkat T cell line JJK (CD4+/CD28+), were nucleofected with
pEGFP, plasmid expressing EGFP using Amaxa nucleofector
system, Amaxa Biosystems, Gaithersburg, MD following manu-
facturer’s instructions. Briefly, the cells were washed and
resuspended in RPMI medium without any supplements at a
concentration of 56106, and 5 mg of plasmid was used to transfect
the cells using appropriate settings. Following nucleofection, cells
were maintained in RPMI supplemented with 10% FBS and 1%
L-glutamate with no antibiotics.
Flow cytometry
In coculture experiments, doublet differentiation was applied to
gate on single cells. Surface staining was performed for DC-SIGN,
in some of the experiments surface staining of CD3 or CD28 was
also included. Briefly, at indicated time points cells were washed
twice with cold PBS (pH 7.2) containing 5% FBS and incubated
with respective fluorochrome conjugated antibody or isotype
control for 1 h at 4uC. To minimize cell aggregates, 5 mM EDTA
was included in the FACS buffer. Samples were fixed with 2%
formaldehyde for 1 hr and analyzed using Epics-XL (Beckman
Coulter, Miami, FL) with minimum of 20,000 gated events
acquired for each sample. Flow Jo software was used to analyze the
results.
Fluorescence labeling
Cells were labeled with membrane labeling dye PKH26 (Sigma-
Aldrich), according to the manufacturer’s instructions. Briefly, the
cells were washed twice in PBS and resuspended in Diluent C at a
concentration of 26106 cells/ml. Cells were added to an equal
volume of PKH26 (4 mM) in Diluent C, and incubated for 5 min
at room temperature. An equal volume of FCS was added
following which the cells were resuspended in complete medium
and washed four times. The stained cells were incubated in
appropriate medium for 4 hours before using them in coculture
experiments.
Inhibition and blocking assays
Two hours prior to coculture with infected cells, immature or
mature MDDC were pretreated with the inhibitor/blocker. Anti-
DC-SIGN, and anti-DC-SIGN-R antibody were obtained from
R&D Systems; Integrase inhibitor (118-D-24), T-20 Fusion
inhibitor, TAK 779, AMD3100 were obtained through the NIH
AIDS Research and Reference Reagent Program, Division of
AIDS, NIAID, NIH; and all other inhibitors were obtained from
Sigma-Aldrich.
Immunofluorescence
At indicated time points, cells were adhered to glass slides, and
fixed using 3.7% formaldehyde at room temperature for 10 min,
and washed with PBS. Following three washes, slides were blocked
with PBS containing 5% FBS. Surface staining was performed
with primary antibody (DC-SIGN or CD28) (1:100 dilution, R&D
Systems, or BD Biosciences) for 1 hr at 4uC. Cells were washed 3
times with wash buffer, and incubated with rabbit anti-mouse IgG
Rhodamine (RRX) (1:400; Jackson ImmunoResearch, West
Grove, PA) or donkey anti mouse Cy3 (1:1000; Jackson
ImmunoResearch, West Grove, PA) or donkey anti-rabbit Alexa
488 (1:1000; Molecular Probes) for 1 h at room temperature
followed by nuclear staining with Hoechst or DAPI. Confocal
microscopy was performed using Olympus 1000 scanning confocal
microscope from Olympus America at the Center for Biological
Imaging, University of Pittsburgh. Final composites were con-
structed in Adobe Photoshop CS (Adobe, San Jose, CA).
Assay for Integrated HIV-1 DNA
To evaluate the integrated DNA in infected DC, infected DC
(based on EGFP+/DC-SIGN+ double positive) were sorted using
the MoFlo sorter at UPCI Biocontainment Flow facility with the
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purity of 100%. Sorted DC were evaluated for integrated HIV-1
DNA by real time Alu-LTR PCR method as described in Butler et
al [55]. Briefly Cellular DNA was extracted from sorted cells using
Qiagen QIAamp DNA Blood Mini Kit, and 500 ng of DNA was
used for PCR reaction, along with 50 nM forward primer,
300 nM reverse primer and 100 nM of probe. The sequence of
primers and probes are described in Butler et al [55].
Statistical analysis
The results were expressed as mean6standard deviation. The
data were analyzed using the Student’s t test for paired samples.
Statistical evaluation of relation between antigen uptake and DC
infection was performed using linear regression analysis and R2
value was calculated.
Supporting Information
Figure S1 (A) Phenotypic and functional analysis of Immature
and Mature DC. DC were differentiated from CD14+ monocytes
as described in Materials and Methods, stimulated with 1mg/ml
LPS, and stained with CD1a, CD80, CD83, CD86 and HLA-DR
monoclonal antibodies or were incubated with FITC-dextran for
50 min at 37uC or 4uC, and analyzed by flow cytometry. Overlay
of histogram shows surface expression of CD1a, CD80, CD83,
CD86 and HLA-DR in Immature (blue) and mature DC (red).
Isotype control is represented in black. (B) Histogram indicates
FITC fluorescence in immature and mature DC at 37uC (green) or
4uC (blue), last panel shows overlay of histogram comparing FITC
in immature (dashed blue) and mature (dashed red) DC at 37uC.
(C) Schematic of HIV-1wt-EGFP and HIV-1 delta Env-EGFP
proviral constructs denoting the position of EGFP and IRES. (D)
Comparison of MFI of EGFP fluorescence in HIV-1wt-EGFP
reporter virus infected and EGFP plasmid transfected Jurkat T
cells.
Found at: doi:10.1371/journal.pone.0007470.s001 (0.13 MB
DOC)
Figure S2 DC infection vs antigen uptake. DC were cocultured
with either HIV-1wt-EGFP reporter virus-infected Jurkat T cells
or with Jurkat cells expressing EGFP protein. Post coculture, the
cells were stained for DC-SIGN and analyzed by confocal
microscopy. DC infection, represents DC cells productively
infected and expressing EGFP (was measured by EGFP distribu-
tion throughout the cell); DC uptake, represents DC take up
EGFP protein (exhibit the punctate pattern). Red, indicates DC-
SIGN positive cells.
Found at: doi:10.1371/journal.pone.0007470.s002 (0.94 MB TIF)
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